Monitoring symptoms during lymphoma treatment
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study uses an electronic monitoring system to track symptoms for people starting standard treatment for large B-cell lymphoma. You'll report how you feel using an app or website, which may help your care team respond sooner if issues arise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have large B-cell lymphoma that has not yet been treated.
- Your doctor plans to treat you with R-CHOP or R-mini-CHOP as your first treatment.
- You are 18 years or older.
- You have internet access at home, or someone who can help you send your symptoms online.
- Your general health is good enough that you can walk and do most daily activities (you are not too sick).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a specific treatment plan to see how well it works for adults with newly diagnosed non-Hodgkin lymphoma that has a high amount of disease. It may help by aiming to control lymphoma more effectively, especially when it is widespread.
This study looks for biomarkers (biological signs) in blood or tissue samples from people with diffuse large B-cell lymphoma (DLBCL) to help predict how the disease behaves and how well treatment might work. Participation involves giving extra biopsy or blood samples during routine care.
This trial tests whether using a smartphone app to report symptoms helps patients feel better and manage side effects during cancer treatment. If you have cancer at any stage and are on systemic therapy, you may be able to join.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
This registry tracks people with non-Hodgkin lymphoma who are starting a new line of systemic therapy. It collects information to better understand how treatments work in real life, and optionally asks you to fill out surveys about your symptoms and quality of life.
This study uses a smartphone or web app to track infections and quality of life in people with multiple myeloma or chronic lymphocytic leukemia who have a weakened immune system. The goal is to create a better screening tool for infections and understand how the disease and treatment affect daily life.
Hear when a new Diffuse Large B Cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.